ArticleJournal of thoracic disease2020
Implications of the success of EGFR-targeted therapy in advanced non-small cell lung cancer for its application to the adjuvant setting.
Masayuki TakedaPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.